| Literature DB >> 33233849 |
Kuo Xu1, Xu-Lun Wei2, Lin Xue3, Zhong-Feng Zhang1, Peng Zhang1.
Abstract
One new meroterpenoid-type alkaloid, oxalicine C (1), and two new erythritol derivatives, penicierythritols A (6) and B (7), together with four known meroterpenoids (2-5), were isolated from the marine algal-derived endophytic fungus Penicillium chrysogenum XNM-12. Their planar structures were determined by means of spectroscopic analyses, including UV, 1D and 2D NMR, and HRESIMS spectra. Their stereochemical configurations were established by comparing the experimental and calculated electronic circular dichroism (ECD) spectra for compound 1, as well as by comparison of the optical rotations with literature data for compounds 6 and 7. Notably, oxalicine C (1) represents the first example of an oxalicine alkaloid with a cleaved α-pyrone ring, whereas penicierythritols A (6) and B (7) are the first reported from the Penicillium species. The antimicrobial activities of compounds 1-7 were evaluated. Compounds 1 and 6 exhibited moderate antibacterial effects against the plant pathogen Ralstonia solanacearum with minimum inhibitory concentration (MIC) values of 8 and 4 μg/mL, respectively. Compound 6 also possesses moderate antifungal properties against the plant pathogen Alternaria alternata with a MIC value of 8 μg/mL.Entities:
Keywords: Penicillium; algal; antimicrobial activity; endophytic fungus; meroterpenoids
Mesh:
Substances:
Year: 2020 PMID: 33233849 PMCID: PMC7699931 DOI: 10.3390/md18110578
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of the isolated compounds 1–7 and the previously reported analogs, 15-deoxyoxalicine B, d-(+)-montagnetol, d-(−)-montagnetol, and d-(−)-erythrin.
1H (500 MHz, δ in ppm, J in Hz) and 13C NMR (125 MHz) data of compound 1 in DMSO-d6.
| Position | Position | ||||
|---|---|---|---|---|---|
| 2 | 8.89 (s) | 148.3, CH | 21a | 1.89 (t, 12.5) | 25.3, CH2 |
| 3 | 128.5, C | 21b | 0.77 (d, 12.5) | ||
| 4 | 8.14 (d, 8.0) | 135.0, CH | 22a | 2.18 (t, 14.0) | 27.6, CH2 |
| 5 | 7.50 (m) | 123.5, CH | 22b | 1.31 (d, 14.0) | |
| 6 | 8.66 (d, 4.5) | 151.4, CH | 23 | 75.1, C | |
| 7 | 186.4, C | 24 | 44.0, C | ||
| 9 | 164.3, C | 25a | 2.27 (overlap) | 25.8, CH2 | |
| 10 | 140.5, C | 25b | 1.45 (d, 15.5) | ||
| 11 | 170.5, C | 26a | 2.42 (dt, 14.0, 5.0) | 29.7, CH2 | |
| 12 | 7.09 (s) | 94.0, CH | 26b | 2.20 (overlap) | |
| 14 | 99.0, C | 27 | 173.6, C | ||
| 15 | 7.32 (s) | 148.4, CH | 29 | 4.43 (s) | 67.0, CH2 |
| 16 | 135.6, C | 30 | 1.36 (s) | 19.5, CH3 | |
| 17 | 5.75 (s) | 127.8, CH | 31 | 0.94 (s) | 18.1, CH3 |
| 18a | 2.29 (overlap) | 23.6, CH2 | 32 | 150.5, C | |
| 18b | 2.06 (d, 18.0) | 33a | 5.08 (s) | 114.3, CH2 | |
| 19 | 2.57 (dd, 5.0, 12.0) | 41.5, CH | 33b | 4.84 (s) | |
| 20 | 40.4, C | 34 | 1.75 (s) | 21.7, CH3 |
Figure 2(A–C) COSY and key HMBC correlations of 1, 6, and 7, respectively; (D) Key NOESY correlations of 1.
Figure 3The theoretical calculations for compound 1. (A) experimental and calculated ECD spectra of 1; (B) correlation between the calculated and experimental 13C NMR data of 1.
1H (500 MHz) and 13C NMR (125 MHz) data of compounds 6 and 7 in DMSO-d6.
| No. | Compound 6 | Compound 7 | ||
|---|---|---|---|---|
| 1a | 4.44 (d, 11.0) | 67.2, CH2 | 4.24 (d, 11.0) | 66.2, CH2 |
| 1b | 4.26 (dd, 11.0, 7.0) | 4.01 (dd, 11.0, 7.5) | ||
| 2 | 3.71 (m) | 69.2, CH | 3.59 (m) | 69.4, CH |
| 3 | 3.42 (overlap) | 72.5, CH | 3.38 (overlap) | 72.3, CH |
| 4a | 3.58 (m) | 63.0, CH2 | 3.55 (m) | 63.1, CH2 |
| 4b | 3.36 (overlap) | 3.39 (overlap) | ||
| 1′ | 103.6, C | 166.5, C | ||
| 2′ | 161.1, C | 5.88 (d, 15.5) | 119.3, CH | |
| 3′ | 108.2, C | 7.24 (dd, 15.5, 10.0) | 145.0, CH | |
| 4′ | 160.7, C | 6.27 (overlap) | 129.8, CH | |
| 5′ | 6.30 (s) | 109.2, CH | 6.25 (overlap) | 142.0, CH |
| 6′ | 145.1, C | 2.22 (m) | 42.6, CH2 | |
| 7′ | 171.0, C | 3.70 (m) | 65.6, CH | |
| 8′ | 1.93 (s) | 8.2, CH3 | 1.05 (d, 6.0) | 23.3, CH3 |
| 9′ | 2.78 (m) | 28.6, CH2 | ||
| 10′ | 1.10 (t, 7.5) | 16.2, CH3 | ||
Minimum inhibitory concentration (MIC) values of compounds 1–7 against pathogenic microorganisms (µg/mL).
| Strains | MIC (µg/mL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | Ch a | Pr b | ||
| Bacteria |
| 8 | >64 | 32 | >64 | >64 | 16 | 32 | 1 | – |
|
| 8 | >64 | 16 | >64 | 32 | 8 | 16 | 1 | ||
|
| 16 | 32 | >64 | >64 | 16 | 8 | >64 | 2 | ||
|
| 8 | >64 | 32 | 32 | 16 | 4 | >64 | 8 | ||
| Fungi |
| >64 | >64 | 32 | 32 | >64 | 8 | >64 | – | 16 |
|
| 32 | >64 | 16 | 32 | 32 | 16 | >64 | 8 | ||
|
| >64 | >64 | 16 | >64 | 32 | 32 | 32 | 8 | ||
|
| 32 | >64 | >64 | 16 | >64 | 32 | 16 | 16 | ||
|
| 16 | >64 | >64 | 16 | 32 | 16 | 16 | 4 | ||
a chloramphenicol; b prochloraz.